Relugolix manufacturer

Relugolix(Relugolix) is developed and produced by Takeda Pharmaceuticals. European version pharmacy retail price120mg30Tablets4500yuan, the retail price in Japanese pharmacies40mg120tablets7200yuan. FDAapprovalrepagliflozin was based on evidence from a clinical trial (NCT03085095), which The trial involved 930 participants aged 48 to 97 with advanced prostate cancer. The trial was conducted at 155 sites in the United States, Canada, South America, Europe and Asia Pacific. All participants in the trial had advanced prostate cancer. Participants were randomly assigned to receive one daily tablet of Repagliflozin (they received three tablets on the first day) or an active control group (leuprolide acetate) injected subcutaneously every three months. Both participants and healthcare providers were aware of ongoing treatments. Treatment lasted48 weeks. The efficacy of Repagliflox was assessed by the percentage of participants who achieved and maintained low testosterone levels equivalent to castration. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.